Biol Reprod Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


BOR - Papers in Press, published online ahead of print October 14, 2002.
Biol Reprod 2002, 10.1095/biolreprod.102.006361
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
68/1/51    most recent
biolreprod.102.006361v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dettin, L.
Right arrow Articles by Maldonado, C. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dettin, L.
Right arrow Articles by Maldonado, C. A.
Agricola
Right arrow Articles by Dettin, L.
Right arrow Articles by Maldonado, C. A.
BIOLOGY OF REPRODUCTION 68, 51–59 (2003)
DOI: 10.1095/biolreprod.102.006361
© 2003 by the Society for the Study of Reproduction, Inc.


Male Reproductive Tract

Regulated Expression and Ultrastructural Localization of Galectin-1, a Proapoptotic ß-Galactoside-Binding Lectin, During Spermatogenesis in Rat Testis1

Luis Dettina, Natalia Rubinsteinb, Agustín Aokia, Gabriel A. Rabinovich3,b, and Cristina A. Maldonado2,3,a

a Center of Electron Microscopy, School of Medical Sciences, National University of Cordoba, C.P. 5000, Córdoba, Argentina b Division of Immunogenetics, School of Medicine, University of Buenos Aires, C.P. 1120, Buenos Aires, Argentina


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Galectin-1, a highly conserved ß-galactoside-binding protein, induces apoptosis of activated T cells and suppresses the development of autoimmunity and chronic inflammation. To gain insight regarding the potential role of galectin-1 as a novel mechanism of immune privilege, we investigated expression and ultrastructural localization of galectin-1 in rat testis. Galectin-1 expression was assessed by Western blot analysis and immunocytochemical localization in testes obtained from rats aged from 9 to 60 days. Expression of this carbohydrate-binding protein was developmentally regulated, and its immunolabeling exhibited a stage-specific pattern throughout the spermatogenic process. Immunogold staining using the anti-galectin-1 antibody revealed the typical Sertoli cell profile in the seminiferous epithelium, mainly at stages X–II. During spermiation (stages VI–VIII), a strong labeling was observed at the luminal pole of seminiferous epithelium, localized on apical stalks of Sertoli cells, on heads of mature spermatids, and on bodies of residual cytoplasm. Moreover, spermatozoa released into the lumen showed a strong immunostaining. Following spermiation (stage VIII), galectin-1 expression was restored at the basal portion of Sertoli cells and progressively spread out through the whole cells as differentiation of germinal cells proceeded. Immunoelectron microscopy confirmed distribution of galectin-1 in nuclei and cytoplasmic projections of Sertoli cells and on heads and tails of late spermatids and residual bodies. Surface localization of galectin-1 was evidenced in spermatozoa from caput epididymis. Thus, the regulated expression of galectin-1 during the spermatogenic cycle suggests a novel role for this immunosuppressive lectin in reproductive biology.

apoptosis, immunology, Sertoli cells, spermatogenesis


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
During the last decade, many carbohydrate-binding proteins, or lectins, have been documented to play critical roles in cell trafficking, signaling, and inflammation [1]. Galectins are members of a large, growing family of animal lectins that are highly conserved throughout animal evolution [13]. They share remarkable sequence similarities in the carbohydrate-recognition domain (CRD), and many family members preferentially recognize galactoside-containing saccharide ligands. At present, 14 mammalian galectins have been formally identified in a wide variety of tissues from several species [4]. Galectin-1 (Gal-1), a prototype member of this family, is secreted as a noncovalently linked homodimer with two ligand-binding sites capable of mediating cell-cell and cell-matrix interactions [2]. It is highly expressed by several cell types, including thymic epithelial cells [5], stimulated macrophages [68], antigen-primed T cells [9], activated B cells [10], and Müller glial cells of the retina [11].

By cross-linking T-cell surface glycoproteins, Gal-1 induces apoptosis of activated, but not resting, T cells through ERK (extracellular regulated kinase) phosphorylation and activation of specific transcription factors [7, 1214]. Moreover, at concentrations under its apoptotic threshold, this ß-galactoside-binding protein inhibits T-cell adhesion to extracellular matrix glycoproteins and proinflammatory cytokine secretion [15].

Galectin-1 has immunosuppressive and anti-inflammatory effects in experimental models of autoimmunity and chronic inflammation [16, 17]. We have recently shown, using gene-therapy strategies, that Gal-1 ameliorates inflammation in a collagen-induced arthritis model [16]. Investigation of the molecular mechanisms involved in this process revealed that Gal-1 treatment increases T-cell susceptibility to activation-induced cell death and promotes a shift from a Th1 to a Th2 cytokine profile [16]. We have also shown that Gal-1 plays a key role in the resolution of acute inflammation [18].

Because of its ability to inhibit T-cell effector functions, we hypothesized that expression of endogenous Gal-1 could function as a novel mechanism to confer immune privilege to vulnerable sites such as reproductive cells. Immune privilege is a term applied to several tissues having a unique relationship with the immune response. These sites prevent the spread of inflammation, because even minor episodes can threaten organ integrity and function [19, 20]. The most prominent examples are the eye, the brain, the testis, and the ovary, in which immune responses either do not proceed or proceed in a manner different from that in other areas [20]. It has long been known that the testis is an immunologically privileged site and that the human seminal plasma possesses a generalized immunosuppressive activity [19]. Multiple factors participate in the establishment of immunotolerance in the testis, such as the blood-testis barrier and the local production of immunosuppressive molecules and proapoptotic mediators by Sertoli cells [2024]. The latter also express high levels of Fas ligand, which has been shown to initiate the killing of Fas-bearing infiltrating T cells and Fas-expressing defective germ cells [2527]. However, recent findings suggest that Fas ligand has controversial proinflammatory effects, suggesting that other apoptotic mediators might contribute to the establishment of the immune privilege [28]. Interestingly, immunohistochemical studies showed that Gal-1 is expressed profusely at sites of immune privilege, where the regulation of apoptotic processes is crucial [11, 29, 30]. Furthermore, this sugar-binding protein might also contribute to interactions between different cell types at some stages during spermatogenesis and during sperm-egg binding.

In the present study, we investigated the expression and ultrastructural localization of Gal-1 in normal rat testis by Western blot analysis, immunohistochemistry, and immunoelectron microscopy as well as its regulation during postnatal testis development.


    MATERIALS AND METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Animals

Male Wistar rats (aged 9, 15, 30, 45, and 60 days) were used in this study. Animals were housed and cared for at the Animal Resource Facilities, Faculty of Medical Sciences, National University of Córdoba, in accordance with the National Research Council publication Guide for Care and Use of Laboratory Animals and institutional guidelines. Animals were maintained under a photoperiod of 14L:10D with food and water available ad libitum.

Tissue Processing

Animals were anesthetized with an i.p. injection of a chloral hydrate solution (0.25 g/kg body weight). One testis was dissected, minced, and homogenized in 1 ml of ice-cold lysis buffer (PBS containing 5 mM EDTA, 1% [w/v] NP40, 0.5% [w/v] sodium deoxycholate, 0.1% [w/v] SDS, 124.5 mM KCl, 5 mM MgCl2, and 10 mM Hepes [pH 7.2]) plus protease-inhibitor cocktail (0.2 mM PMSF, 0.1% [w/v] aprotinin. 0.7 µg/ml of pepstatin, and 1 µg/ml of leupeptin) and incubated for 30 min on ice. Samples were finally centrifuged at 15 000 x g for 20 min at 4°C, and the supernatant fluid of the whole-tissue homogenates was stored at -70°C until use. Protein concentration was estimated by using the micro-BCA Protein Assay reagent kit (Pierce, Rockford, IL).

The other testis was fixed by perfusion with 4% paraformaldehyde in 0.1 M cacodylate buffer at pH 7.4 and then embedded in paraffin for light-microscopic immunocytochemistry. For ultrastructural immunocytochemistry, testes perfused with a mixture of 4% paraformaldehyde and 1.5% glutaraldehyde were cut with razor blades in small pieces (1 x 1 x 2 mm) and embedded in LR-White (London Resin Co, Hampshire, U.K.) after partial dehydration in increasing concentrations of ethanol solutions up to 90%, followed by incubation overnight in pure monomer and polymerization at 50°C.

Western Blot Analysis

The SDS-PAGE was carried out in a Miniprotean II electrophoresis apparatus (Bio-Rad, Richmond, CA) as described by Laemmli [31]. Briefly, total tissue homogenates corresponding to normal rat testis of 9, 15, 30, and 60 days of age (30 µg of protein each) were diluted in electrophoresis sample buffer and boiled for 90 sec. Equal amounts of proteins for each lysate were then resolved on a 15% separating polyacrylamide slab gel. Protein bands were detected using Coomassie brilliant blue R250. After electrophoresis, the separated proteins were transferred onto nitrocellulose membranes, blocked for 1.5 h using 5% (w/v) nonfat dried milk in PBS containing 0.05% (v/v) Tween-20, and probed for 3 h with a 1:2000 dilution of an anti-Gal-1 polyclonal antibody as described elsewhere [16]. Blots were then incubated for 1 h with a 1:3000 dilution of a horseradish peroxidase-conjugated goat anti-rabbit immunoglobulin (Ig) G (Bio-Rad). Finally, the peroxidase reaction product was developed in 50 mM Tris-HCl (pH 7.4) containing 0.05% (w/v) 4-chloro-1-naphthol and 0.03% (v/v) hydrogen peroxide. Recombinant Gal-1 (rGal-1; kindly donated by Drs. J. Hirabayashi and K.I. Kasai, Faculty of Pharmaceutical Sciences, Teikyo University, Japan) was used as a positive control of immunodetection. Control of specific immunoreaction was performed by incubation of the blots with a rabbit preimmune serum without detecting any reactivity. The anti-Gal-1 antibody was monospecific, because it did not recognize other galectins, such as rGal-3 [10]. Equal loading and extract degradation were checked by Ponceau S staining and by using an anti-{alpha}-tubulin (DM1A) monoclonal antibody. Rainbow protein molecular weight markers were purchased from Bio-Rad. The immunoreactive protein bands were analyzed with the Fotodyne Image Analyzer (Fotodyne, Inc., Hartland, WI). Results were expressed as relative densitometric values by means of the Image Quant software (Molecular Dynamics, Sunnyvale, CA).

Gold-Complex Preparation

Colloidal gold particles (average diameter, 16 nm) were prepared according to the method of Frens [32] using sodium citrate as a reducing agent. Then, particles were adsorbed to an IgG fraction purified from a goat antiserum raised against rabbit IgG (Sigma Chemical Co., St. Louis, MO). Approximately 0.25 µg of protein was necessary to stabilize 1 µl of colloidal gold solution. Finally, the gold complex was centrifuged at 60 000 x g for 2 h before use and the pellet resuspended in PBS containing 0.01% (w/v) polyethylene glycol.

Light Microscopic Immunocytochemistry

For Gal-1 immunodetection by light microscopic immunocytochemistry, paraffin sections (thickness, 5 µm) were mounted on glass slides coated with 1% polylysine, deparaffinized with xylene, and rehydrated. Then, the sections were incubated with a drop of 1% BSA in PBS for 15 min at room temperature in a humidified chamber to block nonspecific binding sites, followed by incubation with rabbit anti-Gal-1 antibody (diluted 1:1000 in 1% BSA-PBS) for 24 h at 4°C. After three washes with PBS, slides were incubated with a 1:6 dilution of the anti-rabbit IgG-gold complex for 1 h at room temperature. A silver enhancement kit (Sigma) was used to visualize the gold particles at the light-microscopic level. After washing with tridistilled water, the sections were mounted on glass slides and studied in a Zeiss Photomicroscope III (Oberkochen, Germany). Spermatogenic stages were identified according to the method of Leblond and Clermont [33], who defined the 14 stages of the seminiferous cycle in the rat.

Ultrastructural Immunohistochemistry

Thin sections cut from LR-White-embedded tissues were mounted on 300-mesh nickel grids. The grids were floated onto a drop of 1% BSA-PBS for 15 min at room temperature. Then, the sections were incubated with rabbit anti-Gal-1 antibody (diluted 1:3000 in BSA-PBS) for 24 h at 4°C. After washing with PBS, the grids were incubated with anti-rabbit IgG-gold complex diluted 1:20 for 30 min at room temperature. Sections were finally examined in a Siemens Elmiskop 101 transmission electron microscope (Karlsruhe, Germany). Controls of immunoreactivity were performed by incubating LR-White thin sections or paraffin sections with normal rabbit serum or by preadsorbing the anti-Gal-1 antibody with rGal-1.

Pre-Embedding Immunolocalization of Gal-1 in Epididymal Spermatozoa

Spermatozoa were obtained from the caput epididymis after several punctures with a 20-gauge hypodermic needle. The epididymal fluid was collected in a glass vessel containing 25 ml of PBS and then placed in an oven at 34°C for 15 min to allow sedimentation of cellular debris. The upper fraction was collected in a centrifuge tube, spun for 10 min at 1000 rpm, and resuspended in PBS. Cells were then washed through subsequent centrifugations. The collected spermatozoa were resuspended in a blocking solution containing 1% normal goat serum in PBS and incubated for 15 min at room temperature. Blocking solution was discarded, and cells were incubated overnight at 4°C with rabbit anti-Gal-1 antibody diluted 1:1000 or in normal rabbit serum (at the same dilution) for control purposes. After washing, bound antibodies were detected with the anti-rabbit Ig-colloidal complex (1:10 dilution) for 30 min at room temperature.

Following three washes, cells were fixed with 1% glutaraldehyde in 0.1 mM cacodylate buffer at pH 7.4 for 1 h and postfixed for 1 h with 1% osmium tetroxide in the same buffer. Then, the samples were dehydrated in a series of graded acetones and embedded in Araldite (Electron Microscopy Sciences, Fort Washington, PA). Thin sections cut in a Porter-Blum MT2 ultramicrotome (Sorvall Inc., Newtown, CT) were studied in a Siemens Elmiskop 101 electron microscope.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
In the present study, we investigated the expression of Gal-1 in adult rat testis by means of Western blot analysis and immunohistochemistry. Also, we examined the ultrastructural distribution of Gal-1 by immunoelectron microscopy using the immunogold technique on thin sections of rat testis. Finally, we explored the expression of this protein at the surface of epididymal spermatozoa applying the pre-embedding technique.

Testis samples of 9-, 15-, 30-, and 60-day-old rats with equal amounts of protein (30 µg) were analyzed by Western blot. As shown in Figure 1, Gal-1 expression increased in an age-dependent manner in postnatal rat testis. A weak immunoreactivity was found in testes of 9- and 15-day-old rats, but a marked increase in Gal-1 expression was observed when testes were obtained from 30- and 60-day-old rats (Fig. 1). This finding suggests a developmentally regulated expression of this ß-galactoside-binding protein in postnatal testis.



View larger version (33K):
[in this window]
[in a new window]
 
FIG. 1. Developmentally regulated expression of Gal-1 in rat testis. Top: Extracts corresponding to postnatal testis of 9-, 15-, 30-. and 60-day-old rats (lanes 1, 2, 3, and 4, respectively) were prepared and processed for Western blot analysis. Samples were lysed in the presence of protease inhibitors, and equal amounts of protein (30 µg) were subjected to SDS-PAGE on a 15% polyacrylamide slab gel and immunoblotted with a rabbit anti-Gal-1 polyclonal antibody (1:1000). Recombinant Gal-1 was used as a positive control of immunodetection (lane 5). Bottom: Immunoreactive protein bands were semiquantified by densitometry and expressed as relative densitometric values. Samples from three different animals at each time-point were used. A representative experiment is shown

Immunohistochemistry of Gal-1 at the light- and electron-microscopic levels with colloidal gold/antibody complex and silver enhancement technique revealed that seminiferous tubules of 9-, 15-, and 30-day-old rats were almost negative. Immunostaining of Gal-1 was first detected at 45 days and restricted to a basal portion of the seminiferous epithelium, where it was associated with the nucleus and cytoplasm of Sertoli cells (Fig. 2A). Moreover, interstitial cells exhibited an intense immunolabeling. In contrast, in the testes of 60-day-old rats, a strong Gal-1 immunoreactivity was detected in all seminiferous tubules, with a typical distribution that appeared to be modulated according to different stages of the spermatogenic process. At stages X and II, gold/silver labeling delineated the typical columnar profile of Sertoli cells stretching from the basal membrane to the lumen of seminiferous tubules (Fig. 2B). At these stages, germ cells and luminal space were found to be negative.



View larger version (160K):
[in this window]
[in a new window]
 
FIG. 2. Immunohistochemical localization of Gal-1 in rat testis at different stages of the spermatogenic process. Sections were immunostained with the anti-Gal-1 polyclonal antiserum and revealed with colloidal gold complex followed by silver enhancement. A) Seminiferous tubules of 45-day-old rats. Staining localized in Sertoli cells (arrow) and in interstitial cells (arrow heads) is shown. BG) Pattern of Gal-1 immunolocalization at different stages of seminiferous tubules (B, stage II; C, stage IV; D, stage V; E, stage VI; F, stage VII; and G, stage VIII). H) Control section incubated with normal rabbit serum. Bar = 70 µm

On the other hand, at the following stage of spermiation, immunolabeling progressively increased at the apical regions of the seminiferous epithelium (Fig. 2, C–G), whereas it diminished at the basal and intermediate levels. At stages VI and VII (Fig. 2, D–F), Gal-1 was localized mainly at the level of late spermatid heads and at apical processes of Sertoli cells, which were tightly associated with developing spermatids before their release into the tubular lumen. In Figure 2F, the strong luminal staining highlights two regions: the first corresponding to late spermatid heads and the second associated with spermatid tails projecting toward the lumen of the seminiferous tubules. At these stages, Sertoli cells were negative in their middle segment (stage VI) (Fig. 2, C and D) or their basal areas (stage VII) (Fig. 2, E and F). Finally, when the spermiation process was completed (stage VIII) (Fig. 2G), specific staining was found in spermatozoa that were free in the tubular lumen, whereas the basal seminiferous epithelium, associated to Sertoli cell nuclei, was being replenished with Gal-1. Spermatocytes and round spermatids were negative at all stages. No labeling was detected in control sections incubated with preimmune serum instead of with primary antibody (Fig. 2H).

Immunoelectron microscopy confirmed the distribution of Gal-1 described at the light-microscopic level. The labeling of Sertoli cells was observed at the apical projections during spermiation (Figs. 3–6); Figure 7 shows control sections incubated with normal rabbit serum. Also, an intense labeling was associated with nuclei and tails of late spermatids still anchored to the epithelium (Figs. 3, 4, and 6) or free in the lumen (Figs. 8 and 9). The cytoplasm of late spermatids exhibited a weak immunogold staining, the density of which increased after transformation into residual bodies (Fig. 10). Furthermore, immunostaining was also found at the thin laminar processes of the apical pole of Sertoli cells that engulfed residual bodies (Fig. 10).



View larger version (132K):
[in this window]
[in a new window]
 
FIG. 5. FIGS. 3 AND 4. Ultrastructural immunolocalization of Gal-1 in adult rat testis. Both micrographs show specific labeling in cytoplasmic projections of Sertoli cells (Sc) that surround spermatid heads (->) at the apical portion of the seminiferous tubule in stage IV. Sp, Round spermatid.Ultrastructural immunolocalization of Gal-1 in adult rat testis. Specific gold labeling in a cytoplasmic projection of a Sertoli cell in the lumen of seminiferous tubule. Bar = 0.6 µm.FIG. 6. Ultrastructural immunolocalization of Gal-1 in adult rat testis. Gold labeling is observed in elongated spermatid heads (->) and tail cross-sections (*) and in the cytoplasm of Sertoli cells (Sc) at the apical portion of the seminiferous tubule in stage V. S, Spermatid. Bar = 0.6 µm.FIG. 7. Ultrastructural immunolocalization of Gal-1 in adult rat testis. Only scarce gold particles (arrow heads) are observed on Sertoli cell (Sc) and spermatid heads (arrows) in a control grid incubated with normal rabbit serum. Bar = 0.6 µm



View larger version (122K):
[in this window]
[in a new window]
 
FIG. 8. Ultrastructural immunolocalization of Gal-1 in adult rat testis. Gold labeling in the nuclei (->) and tail cross-sections of spermatozoids ready to be released to the lumen (stage VII). Bar = 0.6 µm.FIG. 9. Ultrastructural immunolocalization of Gal-1 in adult rat testis. Spermatozoids released to the lumen of seminiferous tubules exhibit an intense gold labeling on longitudinal sections of their tails. Bar = 0.6 µm.FIG. 10. Ultrastructural immunolocalization of Gal-1 in adult rat testis. At stage VIII, residual bodies (RB) in the apical surface of tubules exhibit gold staining. Also, thin cytoplasmic projections of Sertoli cells (arrow head) show specific immunoreactivity. Bar = 0.6 µm.FIG. 11. Pre-embedding immunogold labeling of Gal-1 of epididymal spermatozoids. a and b) Using a specific antibody, the plasma membrane of spermatozoid heads exhibits a strong gold labeling, whereas spermatozoa tails are less immunoreactive. c) When the specific antibody is replaced by normal rabbit serum, only scarce immunogold staining is detected. Bar = 0.6 µm

Finally, strong Gal-1 immunoreactivity was found in epididymal spermatozoa processed for pre-embedding immunoelectron microscopy. A marked staining occurred around the head plasma membrane, whereas a weak immunoreactivity was found in spermatozoa tails (Fig. 11, a and b). To investigate whether Gal-1 exists in the cell surface of spermatozoa by ß-galactoside-dependent binding, lactose (100 mM) was added to the buffer when sperm cells were isolated. Immunostaining was partially inhibited (data not shown), suggesting that at least part of the Gal-1 present at the heads of sperm cells are bound to the cell surface through its CRD.


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Galectin-1 has been shown to induce apoptosis of activated T cells and immature thymocytes through recognition of specific galactoside residues on cell-signaling receptors, such as CD45 and CD43, and extracellular matrix glycoproteins, such as laminin and fibronectin [2, 4]. Expression of galectins was found to be up- or down-regulated during embryogenesis, being a typical hallmark of specific developmental stages [34]. Moreover, Gal-1 expression and subcellular distribution have been reported to be highly susceptible of modulation by diverse stimuli, such as microbial infections [8], metastatic processes [35], and inflammatory agents [6].

In the present study, we reported the expression of Gal-1 regulated throughout postnatal development and its stage-specific distribution in the seminiferous tubules of adult rat testis. Expression of Gal-1 was first detected by Western blot analysis in 9-day-old testis and increased in an age-dependent manner during postnatal development. By immunocytochemistry, positive staining was detected after 45 days at the level of Sertoli cells. After puberty, Gal-1 expression exhibited a stage-specific pattern at the level of Sertoli cells during spermatogenesis. Moreover, heads and tails of late spermatids and spermatozoids were strongly stained, suggesting a potential role for this immunosuppressive protein in the establishment of immune tolerance not only at the level of the male ejaculatory tract but also in the female reproductive tract.

Sertoli cells are somatic cells that stretch from the basal lamina to the lumen of the seminiferous tubules, with key functions in blood-testis barrier development and spermatogenesis [36]. All stages of spermatogenesis take place while the developing gametes are in intimate relationship with Sertoli cells. This facilitates the progression of germ cells to spermatozoa and the control of the milieu within the compartments of seminiferous tubules by means of paracrine signaling. Many functions of Sertoli cells are apparently carried out through a variety of proteins that are secreted to the adluminal compartment, such as the Müllerian-inhibitory substance and inhibin [37]. They also produce a number of immunosuppressive and homeostatic factors [19].

Wollina et al. [30], using immunohistochemistry, recently described the presence of Gal-1 in human testis. In the present study, we provide evidence that the expression and localization of this sugar-binding protein is modulated throughout the different stages of the tubular seminiferous cycle in tight correlation with spermatogenesis. Although we found that all seminiferous tubules express Gal-1 in Sertoli cells, the whole cell body was only stained at stages X–II, corresponding to stages of meiotic division. Moreover, during spermiation stages (stages V–VII), Gal-1 was restricted to apical processes of Sertoli cells, enveloping the heads of mature spermatids and the eccentric lobes of redundant cytoplasm. Following spermiation, Gal-1 was replenished at the basal portion of Sertoli cells and progressively spread out through the whole cell body.

A cyclic activity has been described for Sertoli cells [38], with many genes being differentially expressed during different stages of spermatogenesis. In this sense, a group of growth factors and immunosuppressive products derived from Sertoli cells are secreted during periods of meiotic division, whereas others are only synthesized during spermiation stages [39]. Our observations concerning a cyclic distribution of Gal-1 in Sertoli cells support the idea that these somatic cells might have two different functional modes: a first mode, with maximal levels of mRNA for specific Sertoli cell products roughly found at stages VII–IX, and a second mode, in which maximal levels are found at stages XIII–III [40]. By the time this paper was submitted, Timmons et al. [41] reported that Gal-1 mRNA levels in the mouse are regulated in concert with the spermatogenic cycle following a biphasic pattern in which transcripts are most abundant in Sertoli cells at stages X–XII and fall to undetectable levels at stages VII–VIII.

To gain insight regarding the potential physiological significance of Gal-1 in Sertoli cells in relation to differentiating gametes, it would be relevant to consider the testis as an immunologically privileged site, like the placenta and the ovary. Multiple factors contribute to the establishment of immune privilege, including the blood-testis barrier and the local production of immunosuppressive cytokines and proapoptotic factors [19, 42]. Because Gal-1 is a master regulator of T-cell homeostasis, it might provide to Sertoli cells an alternative mechanism with which to induce apoptosis of infiltrating T cells. This role could be reinforced by Leydig cells, in which we also found Gal-1. These cells have been associated with immunoregulation and have shown lymphocyte-inhibitory activity [43, 44]. On the other hand, mammalian testis exhibits a high rate of apoptosis of spermatogenic cells and preleptotene spermatocytes to compensate for the abundant mitosis and to eliminate defective cells [45]. Because Gal-1 is mostly expressed in Sertoli cells during postspermiation stages, one might speculate that this lectin contributes to the maintenance of organ integrity in the face of potentially damaging immune reactions or prevents the generation of defective germ cells. Moreover, Gal-1 might participate in Sertoli cell-sperm and sperm-sperm interactions. In this context, Akama et al [46] have recently shown that N-glycan structures play a key role in Sertoli cell-sperm adhesion and that specific carbohydrates are required for spermatogenesis. The precise functional significance of Gal-1 expression during this process is currently under investigation.

Previous studies have indicated that the cyclic activity of Sertoli cells ceases in the absence of germ cells, suggesting that signals originating from germ cells are important in regulating the spermatogenic cycle [47]. Significantly, in our present study, localization of Gal-1 at a basal position of Sertoli cells before puberty (45 days of postnatal development) occurs after the development of the blood-testis barrier and the simultaneous appearance of zygotene-pachytene spermatocytes [48]. As the differentiation of spermatids proceeds, Gal-1 becomes more prominent in structures located at the apical pole of seminiferous tubules. These observations highlight the importance of Sertoli-germ cell interactions in the establishment of the cyclic functional and morphological activity of the seminiferous epithelium. In agreement with these observations, Timmons et al. [41] suggested that the spermatogenic cycle depended exclusively on the Sertoli cells, because the coordinated cyclic patterns of gene expression in these cells was already established in the prepubertal mouse when gonocytes were arrested at a quiescent stage of the cell cycle.

By means of immunoelectron microscopy, we have also demonstrated the presence of Gal-1 in late spermatids and spermatozoa. This novel and intriguing finding puts forward the hypothesis that this proapoptotic protein might play a crucial role in reproduction. It could provide a novel immunosuppressive mechanism based on protein-carbohydrate interactions to prevent inflammation along the ejaculatory tract as well as in the female genital tract. On the other hand, Gal-1 might also be necessary for germ cell maturation by modulating the activity of several glycoproteins through its CRD.

Furthermore, a role has also been suggested for carbohydrate-binding sperm proteins in the sequence of binding events during fertilization [49]. In this context, Gal-1 might play a role in sperm-egg interactions through binding to specific polylactosamine sugars.

Based on our observations, it is still not clear whether Gal-1 is synthesized by spermatids or is transferred from Sertoli cells to late spermatids. It seems to be unlikely that late spermatids containing highly condensed chromatin and scant cytoplasmic organelles could synthesize proteins actively. Moreover, many secretory products that occur in high concentration in the Sertoli cell cytoplasm appear, finally, as an integral component of the seminal fluid [50]. In this sense, it might be speculated that Sertoli cells could transfer Gal-1 to germ cells; although galectins are cytosolic proteins that lack a signal peptide, they are secreted by a novel apocrine mechanism or are targeted to subcytosolic compartments [51]. However, the high immunoreactivity found in residual bodies during the spermiation stage of the cycle might indicate that Gal-1 is actually synthesized by spermatids and is then targeted to the nucleus or the plasma membrane. Both hypotheses are currently under consideration.

Targeted disruption of the Gal-1 gene in knockout mice resulted in the absence of major phenotypic abnormalities [52]. These animals were fertile and showed normal spermatogenesis and no chronic inflammation. This suggests that other members of the family might compensate for the absence of this sugar-binding protein, as suggested for null mutations in particularly important genes.

We conclude that Gal-1 expression and cellular localization are developmentally regulated in postnatal rat testis throughout different stages of spermatogenesis. The regulated expression in Sertoli cells, late spermatids, and spermatozoids suggests an unknown role for this immunosuppressive protein during reproduction. The current wealth of new information regarding the galectin family promises a ripe field that will expose undisclosed mechanisms involved in the control of basic cellular processes, such as proliferation, apoptosis, and signal transduction, in sites of immune privilege [4]. Finally, it could also provide new therapeutic strategies in chronic inflammatory disorders such as autoimmune orchitis.


    ACKNOWLEDGMENTS
 
We thank Drs. J. Hirabayashi and K. Kasai for providing rGal-1 and Dr. L. Fainboim for continuous support. We are indebted to Lucía Artino, Mercedes Guevara, and Fabrizzio Zaldivar for their cooperation and excellent technical work. A.A., G.A.R., and C.M. are members of the scientific career from CONICET. N.R. thanks CONICET for the fellowship granted.


    FOOTNOTES
 
1 Supported by grants from Fundación Sales, Fundación Roemmers, and Fundación Antorchas (early career grant) to G.A.R and from Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET) to C.A.M. Back

2 Correspondence: Cristina Maldonado, Centro de Microscopía Electrónica, Facultad de Ciencias Médicas, Universidad Nacional de Córdoba, Casilla Postal 362, 5000 Córdoba, Argentina. FAX: 54351 4333021; cmaldon{at}cmefcm.uncor.edu Back

3 G.A.R. and C.A.M. contributed equally to this work Back

Received: 11 April 2002.

First decision: 28 April 2002.

Accepted: 30 July 2002.


    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Barondes SH, Castronovo V, Cooper DNW, Cummings RD, Drickamer K, Feizi T, Gitt MA, Hirabayashi J, Hughes C, Kasai K, Leffler H, Liu F, Lotan R, Mercurio AM, Monsigni M, Pillai S, Poirier F, Raz A, Rigby PWJ, Rini JM, Wang JL. Galectins: a family of animal galactoside-binding lectins. Cell 1994 76:597-598[CrossRef][Medline]
  2. Rabinovich GA, Baum LG, Tinari N, Paganelli R, Natoli C, Liu F-T, Iacobelli S. Galectins and their ligands: amplifiers, silencers or tuners of the inflammatory response. Trends Immunol 2002 23:313-320[CrossRef][Medline]
  3. Liu F-T. Galectins: a new family of regulators of inflammation. Clin Immunol 2000 97:79-88[CrossRef][Medline]
  4. Rabinovich GA, Rubinstein N, Fainboim L. Unlocking the secrets of galectins: a challenge at the frontiers of glycoimmunology. J Leukoc Biol 2002 71:741-752[Abstract/Free Full Text]
  5. Baum LG, Pang M, Perillo NL, Wu T, Delegaene A, Uittenbogaart CH, Fukuda M, Seilhamer JJ. Human thymic epithelial cells express an endogenous lectin, galectin-1, which binds to core 2 O-glycans on thymocytes and T lymphoblastoid cells. J Exp Med 1995 181:877-887[Abstract/Free Full Text]
  6. Rabinovich GA, Castagna LF, Landa CA, Riera CM, Sotomayor CE. Regulated expression of a 16-kDa galectin-like protein in activated rat macrophages. J Leukoc Biol 1996 59:363-370[Abstract]
  7. Rabinovich GA, Iglesias MM, Modesti NM, Castagna LF, Todel CW, Riera CM, Sotomayor CE. Activated rat macrophages produce a galectin-1-like protein that induces apoptosis of activated T-cells: a biochemical and functional characterization. J Immunol 1998 160:4831-4840[Abstract/Free Full Text]
  8. Zúñiga EI, Gruppi A, Hirabayashi J, Kasai KI, Rabinovich GA. Regulated expression and effect of galectin-1 on Trypanosoma cruzi-infected macrophages: modulation of microbicidal activity and survival. Infect Immun 2001 69:6804-6812[Abstract/Free Full Text]
  9. Blaser C, Kaufmann M, Muller C, Zimmermann C, Wells V, Mallucci L, Pircher H. ß-Galactoside-binding protein secreted by activated T cells inhibits antigen-induced proliferation of T cells. Eur J Immunol 1998 28:2311-2319[CrossRef][Medline]
  10. Zúñiga E, Rabinovich GA, Iglesias MM, Gruppi A. Regulated expression of galectin-1 during B-cell activation and implications for T-cell apoptosis. J Leukoc Biol 2001 70:73-79[Abstract/Free Full Text]
  11. Maldonado CA, Castagna LF, Rabinovich GA, Landa CA. Immunocytochemical study of the distribution of a 16-kDa galectin in the chicken retina. Invest Ophthalmol Vis Sci 1999 40:2971-2977[Abstract/Free Full Text]
  12. Perillo NL, Pace KE, Seihamer JJ, Baum LG. Apoptosis of T-cells mediated by galectin-1. Nature 1995 378:736-739[CrossRef][Medline]
  13. Vespa GN, Lewis LA, Kozak KR, Moran M, Nguyen JT, Baum LG, Miceli MC. Galectin-1 specifically modulates TCR signals to enhance TCR apoptosis but inhibit IL-2 production and proliferation. J Immunol 1999 162:799-806[Abstract/Free Full Text]
  14. Rabinovich GA, Alonso CR, Sotomayor CE, Durand S, Bocco JL, Riera CM. Molecular mechanisms implicated in galectin-1-induced apoptosis: activation of the AP-1 transcription factor and down-regulation of Bcl-2. Cell Death Differ 2000 7:747-753[CrossRef][Medline]
  15. Rabinovich GA, Ariel A, Hershkoviz R, Hirabayashi J, Kasai KI, Lider O. Specific inhibition of T-cell adhesion to extracellular matrix and proinflammatory cytokine secretion by human recombinant galectin-1. Immunology 1999 97:100-106[CrossRef][Medline]
  16. Rabinovich GA, Daly G, Dreja H, Tailor H, Riera CM, Hirabayashi J, Chernajovsky Y. Recombinant galectin-1 and its genetic delivery suppress collagen-induced arthritis via T cell apoptosis. J Exp Med 1999 190:385-397[Abstract/Free Full Text]
  17. Santucci EL, Fiorucci S, Cammilleri F, Servillo G, Federici B, Morelli A. Galectin-1 exerts immunomodulatory and protective effects on concanavalin-A-induced hepatitis in mice. Hepatology 2000 31:399-407[CrossRef][Medline]
  18. Rabinovich GA, Sotomayor CE, Riera CM, Bianco ID, Correa SG. Evidence of a role for galectin-1 in acute inflammation. Eur J Immunol 2000 30:1331-1339[CrossRef][Medline]
  19. Filippini A, Riccioli A, Padula F, Lauretti P, D'Alessio A, De Cesaris P, Gandini L, Lenzi A, Ziparo E. Control and impairment of immune privilege in the testis and in semen. Hum Reprod Update 2001 7:444-449[Abstract/Free Full Text]
  20. Ferguson TA, Griffith TS. A vision of cell death: insights into immune privilege. Immunol Rev 1997 156:167-184[CrossRef][Medline]
  21. Pöllänen P, von Euler M, Sainio-Pollanen S, Jahnukainen K, Hakovirta H, Soder O, Parvinen M. Immunosuppressive activity in the rat seminiferous tubules. J Reprod Immunol 1992 22:117-126[CrossRef][Medline]
  22. Pöllänen P, von Euler M, Jahnukainen K, Saari T, Parvinen M, Sainio-Pöllänen S, Soder O. Role of transforming growth factor ß in testicular immunosuppression. J Reprod Immunol 1993 24:123-137[CrossRef][Medline]
  23. Selawry HP, Koth M, Herrod HG, Lu ZN. Production of a factor, or factors, suppressing IL-2 production and T-cell proliferation by Sertoli cell-enriched preparations. A potential role for islet transplantation in an immunologically privileged site. Transplantation 1991 52:846-85[Medline]
  24. De Cesaris P, Filippini A, Setchel BP. Immunosuppressive molecules produced by Sertoli cells cultured in vitro: biological effects on lymphocytes. Biochem Biophys Res Commun 1992 186:1639-1646[CrossRef][Medline]
  25. Bellgrau D, Gold D, Selawry H, Moore J, Franzusoff A, Duke RC. A role for CD95 ligand in preventing graft rejection. Nature 1995 377:630-632[CrossRef][Medline]
  26. Lee J, Richburg JH, Younkin SC, Boekelheide K. The Fas system is a key regulator of germ cells apoptosis in the testis. Endocrinology 1997 138:2081-2088[Abstract/Free Full Text]
  27. Pentikainen V, Erkkila K, Dunkel L. Fas regulates germ cell apoptosis in the human testis in vitro. Am J Physiol 1999 276:E310-E316[Abstract/Free Full Text]
  28. Green DR, Ferguson TA. The role of Fas ligand in immune privilege. Nat Rev Mol Cell Biol 2001 2:917-924[CrossRef][Medline]
  29. Phillips B, Knisley K, Weitlauf KD, Dorsett J, Lee V, Weitlauf H. Differential expression of two ß-galactoside-binding lectins in the reproductive tracts of pregnant mice. Biol Reprod 1996 55:548-558[Abstract]
  30. Wollina U, Schreiber G, Gorning M, Feldrappe S, Burchert M, Gabius HJ. Sertoli cell expression of galectin-1 and -3 and accessible binding sites in normal human testis and Sertoli cell-only syndrome. Histol Histopathol 1999 14:779-784[Medline]
  31. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970 227:680-684[CrossRef][Medline]
  32. Frens G. Controlled nucleation of the regulation of the particle size in monodisperse gold solution. Nat Phys Sci 1973 241:20-22
  33. Leblond CP, Clermont Y. Definition of the stages of the cycle of the seminiferous epithelium in the rat. Ann N Y Acad Sci 1952 55:548-573
  34. Poirier F, Robertson EJ. Normal development of mice carrying a null mutation in the gene encoding the L-14 S-type lectin. Development 1993 119:1229-1236[Abstract]
  35. Rabinovich GA, Rubinstein N, Matar P, Rozados V, Gervasoni S, Scharovsky OG. The antimetastatic effect of a single low dose of cyclophosphamide involves modulation of galectin-1 and Bcl-2 expression. Cancer Immunol Immunother 2002 50:597-603[CrossRef][Medline]
  36. Griswold MD. The central role of Sertoli cells in spermatogenesis. Semin Cell Dev Biol 1998 9:411-416[CrossRef][Medline]
  37. Skinner MK. Secretion of growth factors and other regulatory factors. In: Russell LD, Griswold MD (eds.), The Sertoli Cell, vol. 1, 1st ed. Clearwater, FL: Cache River Press; 1993: 237–248
  38. Parvinen M. Cyclic function of Sertoli cells. In: Russell LD, Griswold MD (eds.), The Sertoli Cell, vol. 1, 1st ed. Clearwater, FL: Cache River Press; 1993: 349–364
  39. Griswold MD. Interactions between germ cells and Sertoli cells in the testis. Biol Reprod 1995 52:211-216[Abstract]
  40. Linder CC, Heckert LL, Roberts KP, Kim KH, Griswold MD. Expression of receptors during the cycle of the seminiferous epithelium. Ann N Y Acad Sci 1991 637:313-321[Medline]
  41. Timmons PM, Righby PWJ, Poirier F. The murine seminiferous epithelial cycle is prefigured in the Sertoli cells of the embryonic testis. Development 2002 129:635-647[Abstract/Free Full Text]
  42. Turek PH, Malkowicz SB, Tomaszewski JE, Wein AJ, Peehl D. The role of Sertoli cells in active immunosuppression in the human testis. Br J Urol 1996 77:891-895[CrossRef][Medline]
  43. Pöllänen P, von Euler M, Soder O. Testicular immunoregulatory factors. J Reprod Immunol 1990 18:51-76[CrossRef][Medline]
  44. Hedeger MP, Meinhardt A. Local regulation of T-cell numbers and lymphocyte-inhibiting activity in the interstitial tissue of the adult rat testis. J Reprod Immunol 2000 48:69-80[CrossRef][Medline]
  45. Yin Y, Stahl BC, De Wolf WC, Morgentaler A. p53-Mediated germ cell quality control in spermatogenesis. Dev Biol 1998 204:165-171[CrossRef][Medline]
  46. Akama TO, Nakagawa H, Sugihara K, Narisawa S, Ohyama C, Nishimura S, O'Brien DA, Moremen KW, Millan JL, Fukuda MN. Germ cell survival through carbohydrate-mediated interaction with Sertoli cells. Science 2002 295:124-127[Abstract/Free Full Text]
  47. Jegou B. Spermatids are regulators of Sertoli cell function. Ann N Y Acad Sci 1991 637:340-353[Medline]
  48. Cavicchia JC, Sacerdote FL. Correlation between blood-testis barrier development and onset of the first spermatogenic wave in normal and in busulfan-treated rats: a lanthanum and freeze-fracture study. Anat Rec 1991 230:361-8[CrossRef][Medline]
  49. Topfer-Petersen E. Carbohydrate-based interactions on the route of a spermatozoon to fertilization. Hum Reprod Update 1999 5:314-329[Abstract/Free Full Text]
  50. Sylvester SR, Skinner MK, Griswold MD. A sulfated glycoprotein synthesized by Sertoli cells and by epididymal cells is a component of the sperm membrane. Biol Reprod 1984 31:1087-1101[Abstract]
  51. Cooper DNW, Barondes SH. Evidence for export of a muscle lectin from cytosol to extracellular matrix and for a novel secretory mechanism. J Cell Biol 1990 110:1681-1691[Abstract/Free Full Text]
  52. Poirier F, Robertson EJ. Normal development of mice carrying a null mutation in the gene encoding the L-14 S-type lectin. Development 1993 119:1229-1236



This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
S. J. Rodig, J. Ouyang, P. Juszczynski, T. Currie, K. Law, D. S. Neuberg, G. A. Rabinovich, M. A. Shipp, and J. L. Kutok
AP1-Dependent Galectin-1 Expression Delineates Classical Hodgkin and Anaplastic Large Cell Lymphomas from Other Lymphoid Malignancies with Shared Molecular Features
Clin. Cancer Res., June 1, 2008; 14(11): 3338 - 3344.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
J. Nio and T. Iwanaga
Galectins in the Mouse Ovary: Concomitant Expression of Galectin-3 and Progesterone Degradation Enzyme (20{alpha}-HSD) in the Corpus Luteum
J. Histochem. Cytochem., May 1, 2007; 55(5): 423 - 432.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
I. Camby, M. Le Mercier, F. Lefranc, and R. Kiss
Galectin-1: a small protein with major functions
Glycobiology, November 1, 2006; 16(11): 137R - 157R.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
A. A. Quintar, F. D. Roth, A. L. D. Paul, A. Aoki, and C. A. Maldonado
Toll-Like Receptor 4 in Rat Prostate: Modulation by Testosterone and Acute Bacterial Infection in Epithelial and Stromal Cells
Biol Reprod, November 1, 2006; 75(5): 664 - 672.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
V. A. Biron, M. M. Iglesias, M. F. Troncoso, M. Besio-Moreno, Z. J. Patrignani, O. P. Pignataro, and C. Wolfenstein-Todel
Galectin-1: biphasic growth regulation of Leydig tumor cells
Glycobiology, September 1, 2006; 16(9): 810 - 821.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. A. Toscano, A. G. Commodaro, J. M. Ilarregui, G. A. Bianco, A. Liberman, H. M. Serra, J. Hirabayashi, L. V. Rizzo, and G. A. Rabinovich
Galectin-1 Suppresses Autoimmune Retinal Disease by Promoting Concomitant Th2- and T Regulatory-Mediated Anti-Inflammatory Responses
J. Immunol., May 15, 2006; 176(10): 6323 - 6332.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
M. D. Romero, J. C. Muino, G. A. Bianco, M. Ferrero, C. P. Juarez, J. D. Luna, and G. A. Rabinovich
Circulating Anti-galectin-1 Antibodies Are Associated with the Severity of Ocular Disease in Autoimmune and Infectious Uveitis.
Invest. Ophthalmol. Vis. Sci., April 1, 2006; 47(4): 1550 - 1556.
[Abstract] [Full Text] [PDF]


Home page
GlycobiologyHome page
V. G. Martinez, E. H. Pellizzari, E. S. Diaz, S. B. Cigorraga, L. Lustig, B. Denduchis, C. Wolfenstein-Todel, and M. M. Iglesias
Galectin-1, a cell adhesion modulator, induces apoptosis of rat Leydig cells in vitro
Glycobiology, February 1, 2004; 14(2): 127 - 137.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
68/1/51    most recent
biolreprod.102.006361v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dettin, L.
Right arrow Articles by Maldonado, C. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dettin, L.
Right arrow Articles by Maldonado, C. A.
Agricola
Right arrow Articles by Dettin, L.
Right arrow Articles by Maldonado, C. A.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS